首页> 外文期刊>Histopathology: Official Journal of the British Division of the International Academy of Pathology >Sample size requirement for digital image analysis of collagen proportionate area in cirrhotic livers
【24h】

Sample size requirement for digital image analysis of collagen proportionate area in cirrhotic livers

机译:肝硬化胶原蛋白比例区域数字图像分析的样本量要求

获取原文
获取原文并翻译 | 示例
           

摘要

The requirements for adequate cirrhotic liver biopsy size have not been established for quantitative fibrosis measurements (collagen proportionate area: CPA). We evaluated the CPA of virtual biopsies in cirrhosis to elucidate (i) the amount of tissue required to achieve reliable CPA measurements and (ii) the effect of aetiology on sample size requirements. Method and results: A total of 120 cirrhotic tissue blocks (six aetiologies) were studied. A representative 100mm2 region was selected from each block and a reference CPA measured. Each image (n=120) was divided into 100×1mm2 images; CPA was measured for each 1mm2 and virtual biopsies of different sizes were created from the 1mm2 components. For each virtual biopsy size the probability that the virtual biopsy CPA would be within 5% of the reference CPA was calculated. There were 441000 virtual biopsies. Biopsy size versus probability plots indicated that, for 90% probability that the virtual biopsy CPA can be expected to be within 5% of the reference CPA, 22-28mm2 of analysable tissue is required depending on liver disease aetiology; and that a 75% probability level requires a biopsy with 12-15mm2 of analysable tissue. Conclusion: The sample size required for a given probability level depends on the aetiology of cirrhosis, and this should be taken into account when judging the reliability of cirrhotic liver biopsy CPA.
机译:对于定量肝纤维化测量(胶原蛋白比例面积:CPA),尚未建立足够的肝硬化肝活检尺寸的要求。我们评估了肝硬化中虚拟活检的CPA,以阐明(i)实现可靠CPA测量所需的组织数量,以及(ii)病因对样本量要求的影响。方法和结果:共研究了120种肝硬化组织块(六种病因)。从每个模块中选择一个代表性的100mm2区域,并测量参考CPA。每个图像(n = 120)被分为100×1mm2图像;测量每个1mm2的CPA,并从1mm2的组件创建不同大小的虚拟活检。对于每个虚拟活检尺寸,计算了虚拟活检CPA将在参考CPA的5%之内的概率。有441000虚拟活检。活检尺寸与概率图表明,对于90%的虚拟活检CPA可以预期在参考CPA的5%之内的概率,根据肝脏疾病的病因,需要22-28mm2的可分析组织。并且75%的概率水平要求对12-15mm2的可分析组织进行活检。结论:给定概率水平所需的样本量取决于肝硬化的病因,在判断肝硬化肝活检CPA的可靠性时应考虑到这一点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号